Company Profiles

driven by the PitchBook Platform

Vaxxas

Description

Developer of a needle-free vaccine delivery system. The company develops and commercializes a vaccine delivery technology which consists of an array of thousands of vaccine coated microprojections that perforate into the outer layers of the skin when applied with an applicator device.

2011

Founded

PRIVATE

Status

11-50

Employees

Series B

Latest Deal Type

$19.5M

Latest Deal Amount

$35.2M

Total Amount Raised

Description

Developer of a needle-free vaccine delivery system. The company develops and commercializes a vaccine delivery technology which consists of an array of thousands of vaccine coated microprojections that perforate into the outer layers of the skin when applied with an applicator device.

Website:

www.vaxxas.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Other Healthcare

Primary Office

Suite 304, Level 3 1 Alfred Street Sydney, New South Wales 2000Australia
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Vaxxas's full profile, request a free trial.

Vaxxas Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Vaxxas Investors (5)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Brandon Capital PartnersVenture CapitalMinority000 0000000 0000
HealthCare VenturesVenture CapitalMinority000 0000000 0000
OneVenturesVenture CapitalMinority000 0000000 0000
The Medical Research Commercialisation FundVenture CapitalMinority000 0000000 0000
World Health OrganizationCorporation000 0000000 0000
Brandon Capital Partners Venture Capital
HealthCare Ventures Venture Capital
OneVentures Venture Capital
The Medical Research Commercialisation Fund Venture Capital
World Health Organization Corporation

Vaxxas Executive Team (6)

NameTitleBoard
Seat
Contact
Info
David HoeyChief Executive Officer, President & Board Member
Angus Forster Ph.DChief Development and Operations Officer & Vice President, Research & Development
Ian FrazerAdvisor
Ian RhodesAdvisor
Julian Hickling Ph.DAdvisor
David Hoey Chief Executive Officer, President & Board Member
Angus Forster Ph.D Chief Development and Operations Officer & Vice President, Research & Development
Ian Frazer Advisor
Ian Rhodes Advisor
Julian Hickling Ph.D Advisor

Vaxxas Board Members (7)

NameRepresentingRoleSinceContact
Info
Andrew DenverSelfBoard Member000 0000
David HoeyVaxxasChief Executive Officer, President & Board Member000 0000
Dean Moss Ph.DSelfBoard Member000 0000
Douglas Onsi JDHealthCare VenturesManaging Director000 0000
Mark Ashton Ph.DSelfBoard Member000 0000
Andrew Denver Board Member Self
David Hoey Chief Executive Officer, President & Board Member Vaxxas
Dean Moss Ph.D Board Member Self
Douglas Onsi JD Managing Director HealthCare Ventures
Mark Ashton Ph.D Board Member Self
Request full access to PitchBook